Business Description
Actinogen Medical is an Australian biotech company focused on treating brain disorders linked to abnormal cortisol activity. Its lead product, Xanamem, is a once-daily pill designed to regulate cortisol levels in the brain and is being developed as a potential treatment for conditions such as Alzheimer's disease, major depression, and fragile X syndrome. Founded in 1999 and headquartered in Sydney, the company has been operating under its current name since 2015.
